Characterization of <Emphasis Type="Italic">TRZ1</Emphasis>, a yeast homolog of the human candidate prostate cancer susceptibility gene ELAC2 encoding tRNase Z
(1) Myriad Genetics, Inc., 320 Wakara Way, Salt Lake City, UT 84108, USA;(2) International Agency for Research on Cancer, World Health Organization, 150 Cours Albert-Thomas, 69372 Lyon Cedex 08, France
Abstract:
Background
In humans, mutation of ELAC2 is associated with an increased risk of prostate cancer. ELAC2 has been shown to have tRNase
Z activity and is associated with the γ-tubulin complex.